ArticleJournal of inflammation research2024

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways.

Ran Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.